Sepsis & infection

High expression of L-GILZ transcript variant 1 (glucocorticoid-induced leucine zipper (GILZ) TV 1) is associated with increased 30-day sepsis mortality, and a high expression ratio possibly contraindicates hydrocortisone administration

Crit CarePublished Prospective cohort study with mechanistic cell-culture experiments

Authors' conclusion

High expression of GILZ TV 1 is associated with a higher 30-day sepsis mortality rate.

Study context

Population
Sepsis patients meeting Sepsis-3 criteriaplus U937 cell line (n = 3)
Participants
121 patients
Exposure
High vs lower GILZ transcript variant 1 expression
Outcome
30-day mortality
Follow-up
30 days

Main finding

As reported in the abstract

30-day mortality by GILZ TV 1 expression

Increased GILZ TV 1 within initial day of sepsis onset: fold rise in mortality

2.2

95% CI 1.2–4.3

Increased GILZ TV 1 by day eight: fold increase in mortality

8.5

95% CI 2.0–36.4

Observational data: associations, not effects.

Further findings

High ratio of GILZ TV 1 to all GILZ TVs in patients receiving hydrocortisone (subgroup)

Fold higher mortality rate
2.3

GILZ TV 1 expression in U937 cells

Enhanced by glucocorticoids; unaffected by LPS

GILZ TV 1 expression in septic patients

Increases over course of sepsis and in response to hydrocortisone

Original publication

High expression of L-GILZ transcript variant 1 (GILZ TV 1) is associated with increased 30-day sepsis mortality, and a high expression ratio possibly contraindicates hydrocortisone administration. Crit Care. Published 12 August 2024. doi:10.1186/s13054-024-05056-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.